UnknownNot Applicable

Ocular Changes With Alpha-2 Receptor Agonist.

Egypt150 participantsStarted 2023-01-01

Plain-language summary

selective alpha-2 receptor agonists cause changes in intraocular pressure and pupillary size thus may affect patient quality of life.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Glaucoma suspect cases. * post-refractive surgery cases. Exclusion Criteria: * Cases with prostatic hyperplasia or diabetics that may alter the measurements of pupillary diameter. * Cases with previous history of any retinal intervention or other drugs that may alter intraocular pressure measurements.

What they're measuring

Intraocular pressure

Timeframe: Baseline and 6 months after regular use of the topical eyedrops

Trial details

NCT IDNCT05670015

SponsorBenha University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-10

Contact for this trial

Ahmed Abdelshafy, MD

01222328766 ahmad4lg@gmail.com

View on ClinicalTrials.gov More Glaucoma, Suspect trials